To answer this, mRNA expression of ESR1, ESR2, and GPER1 was compared in lung tissue from healthy controls to individuals with end-stage IPF given that those with IPF tend to have higher TGF-β1 serum levels compared to healthy controls [36]. The gene discussed is GPER1; the disease is idiopathic pulmonary fibrosis.